Pathophysiological Evidence Driven Management of GERD in Neonatal ICU Infants: Randomized Controlled Trial

Medicine & Life Sciences

1. Gastroesophageal Reflux 100%
2. Neonatal Intensive Care Units 66%
3. Randomized Controlled Trials 35%
4. Oryza 22%
5. Proton Pump Inhibitors 20%
6. National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) 15%
7. Therapeutics 13%
8. Benchmarking 10%
9. Electric Impedance 9%
10. Risk Assessment 7%
11. Acids 6%
12. Parents 6%
13. Hospitalization 6%
14. Clinical Trials 6%
15. Pediatrics 5%
16. Costs and Cost Analysis 5%
17. Safety 5%